Effect of adjuvant disease in rats on cyclophosphamide and isophosphamide metabolism.
D000276:Adjuvants, Immunologic; D000818:Animals; D001168:Arthritis / Q000139:chemically induced / Q000378:metabolism*; D002855:Chromatography, Thin Layer; D003035:Cobalt / Q000494:pharmacology; D003124:Colorimetry; D006224:Cricetinae; D003520:Cyclophosphamide / Q000378:metabolism*; D004117:Dimethoate / Q000378:metabolism*; D005620:Freund's Adjuvant; D006087:Graft vs Host Reaction; D008099:Liver / Q000378:metabolism; D051379:Mice; D008815:Mice, Inbred Strains; D008862:Microsomes, Liver / Q000378:metabolism; D012157:Mononuclear Phagocyte System / Q000378:metabolism; D009169:Mycobacterium tuberculosis / Q000276:immunology; D011506:Proteins / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D012890:Sleep / Q000187:drug effects; D013997:Time Factors
D000276:Adjuvants, Immunologic; D011506:Proteins; D003035:Cobalt; D003520:Cyclophosphamide; D005620:Freund's Adjuvant; D004117:Dimethoate